AIMM Therapeutics BV

AIMM Therapeutics BV is a biotech company, established in 2004 as a joint venture between Immpact and the Academic Medical Center (AMC). AIMM Therapeutics develops antibody-based treatments by discovering the most effective antibodies against cancer and infectious diseases that have been isolated from individuals who have overcome such diseases or from immunized animals.